DK0650363T3 - Antivirale kombinationer - Google Patents

Antivirale kombinationer

Info

Publication number
DK0650363T3
DK0650363T3 DK93915909T DK93915909T DK0650363T3 DK 0650363 T3 DK0650363 T3 DK 0650363T3 DK 93915909 T DK93915909 T DK 93915909T DK 93915909 T DK93915909 T DK 93915909T DK 0650363 T3 DK0650363 T3 DK 0650363T3
Authority
DK
Denmark
Prior art keywords
pct
combinations
sec
pharmaceutically acceptable
acceptable derivative
Prior art date
Application number
DK93915909T
Other languages
English (en)
Inventor
Janet Mary Cameron
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of DK0650363T3 publication Critical patent/DK0650363T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
DK93915909T 1992-07-16 1993-07-13 Antivirale kombinationer DK0650363T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929215178A GB9215178D0 (en) 1992-07-16 1992-07-16 Antiviral combinations
PCT/EP1993/001847 WO1994002155A1 (en) 1992-07-16 1993-07-13 Antiviral combinations

Publications (1)

Publication Number Publication Date
DK0650363T3 true DK0650363T3 (da) 1998-09-21

Family

ID=10718844

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93915909T DK0650363T3 (da) 1992-07-16 1993-07-13 Antivirale kombinationer

Country Status (12)

Country Link
US (1) US5612333A (da)
EP (1) EP0650363B1 (da)
JP (1) JPH07508998A (da)
AT (1) ATE162401T1 (da)
AU (1) AU672022B2 (da)
CA (1) CA2140238C (da)
DE (1) DE69316621T2 (da)
DK (1) DK0650363T3 (da)
ES (1) ES2111755T3 (da)
GB (1) GB9215178D0 (da)
GR (1) GR3026141T3 (da)
WO (1) WO1994002155A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9503850D0 (en) * 1995-02-25 1995-04-19 Glaxo Group Ltd Medicaments
US7713739B1 (en) 2000-11-17 2010-05-11 Novartis Vaccines And Diagnostics, Inc. Microparticle-based transfection and activation of dendritic cells

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2660917B1 (fr) * 1990-04-11 1992-11-20 Perrier Rene Pince de prehension et machine de traitement d'objets, notamment de bouteilles, ainsi equipee.
GB9009861D0 (en) * 1990-05-02 1990-06-27 Glaxo Group Ltd Chemical compounds
WO1992017159A2 (en) * 1991-04-03 1992-10-15 Richardson-Vicks Inc. Stabilized emulsion compositions for imparting an artificial tan to human skin
DK0513917T4 (da) * 1991-05-16 2001-06-25 Glaxo Group Ltd Antivirale kombinationer indeholdende nukleosidanaloger

Also Published As

Publication number Publication date
DE69316621T2 (de) 1998-05-07
US5612333A (en) 1997-03-18
JPH07508998A (ja) 1995-10-05
GR3026141T3 (en) 1998-05-29
EP0650363A1 (en) 1995-05-03
DE69316621D1 (de) 1998-02-26
AU672022B2 (en) 1996-09-19
EP0650363B1 (en) 1998-01-21
ATE162401T1 (de) 1998-02-15
WO1994002155A1 (en) 1994-02-03
AU4568993A (en) 1994-02-14
ES2111755T3 (es) 1998-03-16
CA2140238C (en) 2004-04-20
CA2140238A1 (en) 1994-02-03
GB9215178D0 (en) 1992-08-26

Similar Documents

Publication Publication Date Title
TW366347B (en) Antiviral pharmaceutical compositions comprising 1,3-oxathiolane nucleoside analogues
EP1062950A3 (en) 1,3 Oxathiolane nucleoside analogues
DE69230140D1 (de) Antivirale nucleosidkombination
RU94013464A (ru) Нуклеозидные аналоги 1,3-оксатиолана, способ получения, фармацевтическая композиция, способ лечения вирусной инфекции
GEP19991834B (en) Crystalline Oxathiolane Derivatives
PT871465E (pt) Utilizacao de ritonavir (abt-538) para melhorar a farmacocinetica de drogas metabolizadas por citocromo p450 num metodo de tratamento da sida
ES2172533T3 (es) Uso de nonapeptidos y decapeptidos para la preparacion de un medicamento para combatir el sida.
ES2179040T3 (es) Utilizacion de 5-fluoro-2'-desoxi-3'-tiacitidina para el tratamiento de la hepatitis b.
ES8801303A1 (es) Un procedimiento para preparar una formulacion farmaceutica que contiene un 2'3'-didesoxi-nucleosido.
ES2179193T3 (es) Combinaciones sinergicas de zidovudina, 1592u89 y 3tc.
ATE269321T1 (de) Arzneimittel gegen virale erkrankungen
MD1224B2 (en) Application of nucleoside analogues with 1,3-oxathiolan for treatment of hepatitis B
MX9200361A (es) Nuevo uso del antagonista de adenosina.
BR0214806A (pt) Composições farmacêuticos de 5,7,14-triazatetraciclo-{10.3.1.02,11.0,4,9]-hexadeca-2(1 1),3,5,7,9-penteno
MY127808A (en) Use of dideoxy nucleoside analogues in the treatment of viral infections
TW371662B (en) Antiviral acyclic phosphonomethoxyalkyl substituted alkenyl purine and pyrimidine derivatives
DK0650363T3 (da) Antivirale kombinationer
AR005551A1 (es) Un producto de combinación farmacéutico que comprende un nucleósido análogo e inmunosupresores en combinación con un agente citotóxico para el tratamiento de infecciones con el virus del herpes simple
MY137298A (en) Therapeutic nucleosides
MY113560A (en) Use of 5-fluoro-2'-deoxy-3'-thiacytidine for the treatment of hepatitis b
Gonslaves Throw down your crutches and walk
YU34793A (sh) Derivati proteina c
CO4790095A1 (es) Derivados de tienoxacinona inhibodores de la proteasa del herpes